On August 1st, the 13th China Innovation and Entrepreneurship Competition was held in Anqing City, Anhui Province. Zhongke Made stood out with its innovative project of high-end absorbable hemostatic products, winning second place and successfully advancing to the provincial competition.

During the roadshow, Dr. Yang Xiao, a core member of the company's R&D team and a member of the National Science and Technology Wenzhou Research Institute, comprehensively introduced this innovative project from five dimensions: company profile, technology and products, industry and market, business model, financial analysis, and future prospects. Dr. Yang Xiao visually demonstrated the broad prospects of the project and the unique highlights and competitive advantages of the product through detailed industry data and product trial data comparison.

During the judges' questioning session, Dr. Yang Xiao provided excellent and professional answers to various questions raised, winning unanimous praise from the on-site judges. The judges highly praised Zhongkemade's technological strength and market positioning, and have high expectations for its future market performance.

The successful promotion of Zhongke Made marks that it will compete alongside other outstanding innovative projects in the upcoming provincial competition. The Zhongke Made team will continue to carry forward the spirit of innovation and strive to achieve better results in future competitions.

01 Product Introduction

Conventional surgical procedures often use energy instruments such as ultrasonic knives and electric knives, as well as methods such as compression and ligation, to stop bleeding. However, if the above measures do not achieve satisfactory hemostasis results, an effective hemostatic material is urgently needed. At the same time, there is a lack of effective hemostasis methods for small incisions with deep depths, especially for bleeding at unknown bleeding points in surgical incisions.

The absorbable hemostatic microspheres developed by Anhui Zhongke Made Medical Technology Co., Ltd. can play the role of molecular sieve, rapidly absorb blood components, dehydrate blood rapidly, and make platelets, red blood cells and fibrin aggregate on the surface of particles to produce instant gel, so as to achieve immediate hemostatic effect; Simultaneously activate endogenous hemostatic factors, shorten hemostasis time, and complete hemostasis within a few minutes.

The product has passed the type inspection and the test result is qualified. In order to clarify the safety and efficacy of this product in clinical applications, according to the regulations of the National Medical Products Administration (NMPA), pre market clinical trials of this product will be conducted soon. The completion and production of Zhongke Made absorbable hemostatic microspheres means that China will break the foreign monopoly in the field of absorbable hemostatic materials, overcome the bottleneck problem of key core technologies, and meet the urgent demand for this technology product in related fields domestically.

02 Technical Highlights

(1) Adopting special preparation techniques and not using any toxic chemical additives;
(2) Superior hemostatic performance compared to similar products both domestically and internationally;
(3) Degradation rate is faster than similar products;
(4) Based on international technology for improvement, the cost is controllable and conducive to industrial production;
(5) After hemostasis, a flexible gel can be formed to protect damaged tissues;
(6) Degradable and absorbable in the body, no need for secondary surgery to remove, high safety performance.